investigator_perera

Ranjan J. Perera, Ph.D.

Director, Center for RNA Biology, and Professor, Departments of Neurosurgery and Oncology, Johns Hopkins University School of Medicine

About

Dr. Perera is director of the Center for RNA Biology at Johns Hopkins All Children's Hospital, a senior scientist in the Cancer & Blood Disorders Institute and an associate professor of oncology in the Johns Hopkins University School of Medicine. He also has a secondary affiliation with the Johns Hopkins All Children’s Institute for Fundamental Biomedical Research. He uses biology, analytic genomics and bioinformatics to seek patterns that can lead to treatments for aggressive cancers. Dr. Perera’s research focuses on genes and identifying those susceptible to changes that lead to disease. He seeks to identify these changes early in life, which would allow early intervention through surgery or therapies that could prevent or alter the course of the disease.

Dr. Perera worked for several biotech and pharmaceutical companies before joining the faculty at Mercer University’s School of Medicine as an associate professor and director of genomics and research and development at Anderson Cancer Institute at Memorial Health Medical Center. He then worked for the Sanford Burnham Prebys Medical Research Institute before joining Johns Hopkins All Children’s Hospital in 2018. He is also an adjunct faculty in the NCI-designated Cancer Center at Sanford Burnham Prebys Medical Research Institute in La Jolla, California.

Ranjan Perera PhD Winter 2021

Research and Education Building, Rm. 4111
600 Fifth Street S.
St. Petersburg, FL 33701

Phone 727-767-3491

Education

  • M.S., Cytogenetics, Peoples Friendship University Moscow, 1984
  • Ph.D., Molecular Genetics, Moscow University, and DNA Repair and Recombination, University of Gent, Belgium, Adviser: Professor Marc Van Montagu, Ph.D., 1987
  • Post-doctoral fellowship, Gene Targeting and DNA Recombination, Massachusetts Institute of Technology, Adviser: Professor Ethan R. Signer, Ph.D., 1994

Department and Institute Affiliations

  • Department of Oncology, Johns Hopkins University School of Medicine
  • Cancer & Blood Disorders Institute, Johns Hopkins All Children’s Hospital
  • Institute for Fundamental Biomedical Research, Johns Hopkins All Children’s Hospital
  • The Johns Hopkins University and Johns Hopkins Sidney Kimmel Comprehensive Cancer Center

Honors and Awards

  • Honorary Professor, Institute of Biochemistry, Molecular Biology and Biotechnology, University of Colombo, 1999
  • European Economic Community Biotechnology and Genetic engineering scholarship for post graduate studies, 1987

 

Related Insights
News
Perera_Stapleon.jpg

From Bench to Bedside: Why Basic Research Matters

News
MDT.jpg

3rd Annual Neuro-Oncology and RNA Therapeutics Symposium

News
Urine big.jpg

Johns Hopkins Investigators Create New Urine-based Test to ID Prostate Cancers

News
NEW_Drs Komatsu and Perera InsidePage990X765.jpg

Johns Hopkins All Children's Researchers Receive Florida Grants for Cancer Inquiries

News
Ranjan Perera PhD Winter 2021

RNA-Based Therapy Shows Promise Against Aggressive Childhood Brain Tumors in Mice

News
drs-perera-jallo-stapleton.jpg

Focusing in on Medulloblastoma

News
Newsroom Image_Brain.jpeg

Fat Burning-Linked Molecule Promising Target for Most Common Childhood Brain Cancer

News
Ranjan Perera PhD Winter 2021

Researchers Identify Potential Biomarker to Distinguish Two Aggressive Types of Brain Tumors in Children

News
Ranjan J. Perera, Ph.D., awarded a five-year National Institutes of Health (NIH) grant.

Donors Pave the Way for Securing National Institutes of Health Pediatric Cancer Research Grant

News
biopsy-content-01

‘Liquid Biopsy’ for Brain Cancer

News
Ranjan Perera, Ph.D., director of the Center for RNA Biology at Johns Hopkins All Children’s Hospital

Cerebrospinal Fluid May Be Able to Identify Aggressive Brain Tumors in Children

News
Ranjan Perera, Ph.D., director of the Center for RNA Biology at Johns Hopkins All Children’s Hospital

Johns Hopkins All Children’s Scientist Makes Key Cancer Discovery